Dearie Catherine, Linhart Christine, Figueroa Carah, Saumaka Varanisese, Dobbins Timothy, Morrell Stephen, Taylor Richard
School of Population Health, University of New South Wales, Samuels Building, Botany St, Randwick, NSW 2052, Australia.
School of Population Health, University of New South Wales, Sydney, Australia.
Glob Epidemiol. 2024 Jul 20;8:100157. doi: 10.1016/j.gloepi.2024.100157. eCollection 2024 Dec.
Sustainable Development Goal 3.4.1 (SDG3.4.1) targets a one-third reduction in non-communicable disease (NCD) mortality in ages 30-69-years by 2030 (relative to 2015). Directing interventions to achieve this aim requires reliable estimates of underlying cause of death (UCoD). This may be problematic when both cardiovascular diseases (CVD) and diabetes are present due to a lack of consistency in certification of such deaths. We estimate empirically 2013-17 NCD mortality in Fiji, by sex and ethnicity, from CVD, diabetes, cancer, and chronic lower respiratory diseases (CRD), and aggregated as NCD4.
UCoD was determined from Medical Certificates of Cause-of-Death (MCCD) from the Fiji Ministry of Health after pre-processing of mortality data where diabetes and/or hypertension were present in order to generate internationally comparable UCoD. If no potentially fatal complications from diabetes or hypertension accompanied these causes in Part I (direct cause) of the MCCD, these conditions were re-assigned to Part II (contributory cause). The probability of a 30-year-old dying before reaching age 70-years (PoD), by cause, was calculated.
The PoD from NCD4 over 2013-17 differed by sex and ethnicity: in women, it was 36% (95%CI 35-37%) in i-Taukei and 27% (26-28%) in Fijians of Indian descent (FID); in men, it was 41% (40-42%) in both i-Taukei and FID.PoD from CVD, diabetes, cancer and CRD in women was: 18%, 10%, 13% and 1·0% in i-Taukei; 13%, 10%, 5·6% and 1·1% in FID; in men was: 28%, 8.4%, 7·6% and 2·2% in i-Taukei; 31%, 8.3%, 3.5% and 3·1% in FID.
To achieve SDG3.4.1 goals in Fiji by 2030, effective population wide and ethnic-specific interventions targeting multiple NCDs are required to reduce PoD from NCD4: from 36% to 24% in i-Taukei, and 27% to 18% in FID women; and from 41% to 27% in i-Taukei and FID men.
Not applicable.
可持续发展目标3.4.1旨在到2030年将30至69岁人群的非传染性疾病(NCD)死亡率降低三分之一(相对于2015年)。为实现这一目标而进行的干预措施需要对潜在死因(UCoD)进行可靠估计。当心血管疾病(CVD)和糖尿病同时存在时,由于此类死亡证明缺乏一致性,这可能会成为问题。我们根据斐济2013 - 2017年按性别和种族划分的CVD、糖尿病、癌症和慢性下呼吸道疾病(CRD)的非传染性疾病死亡率进行实证估计,并汇总为NCD4。
在对存在糖尿病和/或高血压的死亡率数据进行预处理后,根据斐济卫生部的死亡医学证明书(MCCD)确定潜在死因,以生成国际可比的潜在死因。如果在MCCD的第一部分(直接死因)中,糖尿病或高血压没有伴随这些病因出现潜在致命并发症,则将这些情况重新归类到第二部分(促成死因)。计算了30岁人群在70岁之前因各种原因死亡的概率(PoD)。
2013 - 2017年NCD4的PoD因性别和种族而异:在女性中,伊陶凯族为36%(95%CI 35 - 37%),印度裔斐济人(FID)为27%(26 - 28%);在男性中,伊陶凯族和FID均为41%(40 - 42%)。女性中CVD、糖尿病、癌症和CRD的PoD分别为:伊陶凯族为18%、10%、13%和1.0%;FID为13%、10%、5.6%和1.1%;男性中分别为:伊陶凯族为28%、8.4%、7.6%和2.2%;FID为31%、8.3%、3.5%和3.1%。
为在2030年实现斐济的可持续发展目标3.4.1,需要针对多种非传染性疾病采取有效的全人群和特定种族干预措施,以降低NCD4的PoD:伊陶凯族女性从36%降至24%,FID女性从27%降至18%;伊陶凯族和FID男性从41%降至27%。
不适用。